M79.12 Insurance Policy Changes

ICD-10 M79.12 is officially defined as "Myalgia of auxiliary muscles, head and neck." code M79.12 is referenced in 4 tracked payer policy changes from Independence Blue Cross and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code M79.12 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Independence Blue Cross · Effective Jan 1, 2027High impact
MA11.017k, Trigger Point Injections
Independence Blue Cross Medicare Advantage is restricting trigger point injection coverage effective 01/01/2027 by limiting frequency to 3-4 sessions per 12 months, eliminating corticosteroid and other injectates (anesthetic-only now covered), removing image guidance coverage, and restricting covered diagnoses to myofascial pain (M79.12, M79.18 only). Multiple HCPCS codes for injectates and CPT codes for imaging guidance are now classified as not medically necessary.
Independence Blue Cross · Effective Jan 1, 2027High impact
11.14.02t, Trigger Point Injections
Independence Blue Cross significantly restricts trigger point injection (TPI) coverage effective 01/01/2027: frequency reduced to 3 injections per 12 months (max 4 with documentation), coverage limited to anesthetic-only injections for myofascial pain diagnoses M79.12 and M79.18, image guidance (ultrasound, fluoroscopy, MRI) and corticosteroid injectates are no longer covered, and 13 HCPCS codes and 3 CPT codes are reclassified as not medically necessary.
Aetna · Identified Oct 2, 2026Medium impact
Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries (CPB 0649, reviewed 2026-09-14)
Aetna clinical policy bulletin 0649 (reviewed September 14, 2026) considers extracorporeal shock-wave therapy medically necessary only for calcific tendinopathy of the shoulder that has lasted at least 6 months, has a calcium deposit of 1 cm or more, and has not responded to conservative care. It lists many other musculoskeletal, pain, wound and scar indications as experimental or not covered. The source gives a review date but no effective date, so confirm current applicability before changing workflows.
Aetna · Identified Aug 15, 2026Low impact
Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries (CPB 0649, reviewed 2025-10-02)
This is Aetna Clinical Policy Bulletin 0649, reviewed October 2, 2025 and first found by PolicyChanges in August 2026, so it is historical material and the current version should be confirmed before acting. Aetna covers extracorporeal shock-wave therapy only for calcific tendinopathy of the shoulder with a calcium deposit of at least 1 cm lasting 6 months or more after conservative care has failed, and lists dozens of other musculoskeletal, wound and medical uses as experimental, investigational or unproven.

Watch M79.12

Get one email when a payer policy names M79.12, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code M79.12?

There are 4 tracked policy changes affecting code M79.12, including updates from Independence Blue Cross, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code M79.12?

Payers that have issued tracked updates for code M79.12 include: Independence Blue Cross, Aetna.

How do I get notified when code M79.12 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code M79.12. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code M79.12?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

MA11.017k, Trigger Point Injections

11.14.02t, Trigger Point Injections

Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries (CPB 0649, reviewed 2026-09-14)

Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries (CPB 0649, reviewed 2025-10-02)

What insurance policy changes affect code M79.12?

Which payers have updated policy for code M79.12?

How do I get notified when code M79.12 policy changes?

Why do payers change policies for code M79.12?